Sanjay Shukla Biography and Net Worth

President and CEO, Director of aTyr Pharma

Sanjay S. Shukla, M.D., M.S., has served as our President and Chief Executive Officer and as a director since November 2017. Dr. Shukla served as our Chief Medical Officer from March 2016 to November 2017. From April 2015 to March 2016, Dr. Shukla worked in an advisory capacity for a number of companies, including as a consultant to aTyr from January 2016 to March 2016. Prior to that, from October 2012 to April 2015, Dr. Shukla served as Vice President and Global Head of Integrated Medical Services for Novartis, a biopharmaceutical company, where he led global medical affairs operations, with oversight for all pharma general medicines therapies, both inline and in development. Dr. Shukla served as Chief Executive Officer of RXMD, a clinical development consultancy that assisted in advancing proof of concept for early stage drug candidates, from April 2009 to September 2012. Prior to that, Dr. Shukla served in a variety of clinical development, data analytics and drug safety roles at Vifor Pharma, a biopharmaceutical company, and Aspreva Pharmaceuticals (acquired by Vifor Pharma). Dr. Shukla received his M.D. from Howard University College of Medicine and his Bachelors of Science in Microbiology and Master of Science in Epidemiology and Biostatistics from the University of Maryland.

What is Sanjay Shukla's net worth?: The estimated net worth of Sanjay Shukla is at least $46.83 thousand as of February 4th, 2026. Dr. Shukla owns 153,553 shares of aTyr Pharma stock worth more than $46,834 as of September 29th. This net worth estimate does not reflect any other investments that Dr. Shukla may own. Learn More about Sanjay Shukla's net worth.
How do I contact Sanjay Shukla?: The corporate mailing address for Dr. Shukla and other aTyr Pharma executives is 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121. aTyr Pharma can also be reached via phone at (858) 731-8389 and via email at [email protected]. Learn More on Sanjay Shukla's contact information.
Has Sanjay Shukla been buying or selling shares of aTyr Pharma?: Sanjay Shukla has not been actively trading shares of aTyr Pharma within the last three months. Most recently, Sanjay Shukla sold 3,745 shares of the business's stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $0.98, for a transaction totalling $3,670.10. Following the completion of the sale, the chief executive officer now directly owns 153,553 shares of the company's stock, valued at $150,481.94. Learn More on Sanjay Shukla's trading history.
Who are aTyr Pharma's active insiders?: aTyr Pharma's insider roster includes Jill Broadfoot (CFO), Nancy Denyes (General Counsel), Jane Gross (Director), Paul Schimmel (Director), and Sanjay Shukla (President and CEO, Director). Learn More on aTyr Pharma's active insiders.
Are insiders buying or selling shares of aTyr Pharma?: In the last year, aTyr Pharma insiders bought shares 3 times. They purchased a total of 1,100,000 shares worth more than $962,719.96. In the last year, insiders at the sold shares 3 times. They sold a total of 6,421 shares worth more than $6,292.58. The most recent insider tranaction occured on May, 27th when Director Paul Schimmel bought 100,000 shares worth more than $50,000.00. Insiders at aTyr Pharma own 5.0% of the company. Learn More about insider trades at aTyr Pharma.
Information on this page was last updated on 5/27/2026.

Sanjay Shukla Insider Trading History at aTyr Pharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/4/2026	Sell	3,745	$0.98	$3,670.10	153,553

Sanjay Shukla Buying and Selling Activity at aTyr Pharma

aTyr Pharma Company Overview

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Today's Range

Now: $0.31

$0.27

$0.31

50 Day Range

MA: $0.47

$0.30

$0.57

2 Week Range

Now: $0.31

$0.27

$1.12

Volume

2,356,175 shs

Average Volume

2,523,473 shs

Market Capitalization

$29.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53